chr4-122827001-G-T

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001361665.2(FGF2):​c.-174G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000731 in 1,231,820 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000065 ( 0 hom. )

Consequence

FGF2
NM_001361665.2 5_prime_UTR_premature_start_codon_gain

Scores

1
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.924
Variant links:
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.122514844).
BS2
High AC in GnomAdExome4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FGF2NM_001361665.2 linkuse as main transcriptc.-174G>T 5_prime_UTR_premature_start_codon_gain_variant 1/3 ENST00000644866.2 NP_001348594.1
FGF2NM_001361665.2 linkuse as main transcriptc.-174G>T 5_prime_UTR_variant 1/3 ENST00000644866.2 NP_001348594.1
FGF2NM_002006.6 linkuse as main transcriptc.226G>T p.Gly76Cys missense_variant 1/3 NP_001997.5 P09038-4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FGF2ENST00000644866.2 linkuse as main transcriptc.-174G>T 5_prime_UTR_premature_start_codon_gain_variant 1/3 NM_001361665.2 ENSP00000494222.1 P09038-2
FGF2ENST00000644866.2 linkuse as main transcriptc.-174G>T 5_prime_UTR_variant 1/3 NM_001361665.2 ENSP00000494222.1 P09038-2

Frequencies

GnomAD3 genomes
AF:
0.0000134
AC:
2
AN:
149480
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000298
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000647
AC:
7
AN:
1082340
Hom.:
0
Cov.:
32
AF XY:
0.00000390
AC XY:
2
AN XY:
512570
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000281
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000217
Gnomad4 OTH exome
AF:
0.0000230
GnomAD4 genome
AF:
0.0000134
AC:
2
AN:
149480
Hom.:
0
Cov.:
31
AF XY:
0.0000137
AC XY:
1
AN XY:
72924
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000298
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 25, 2024The c.226G>T (p.G76C) alteration is located in exon 1 (coding exon 1) of the FGF2 gene. This alteration results from a G to T substitution at nucleotide position 226, causing the glycine (G) at amino acid position 76 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
7.6
DANN
Benign
0.92
DEOGEN2
Benign
0.34
.;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0056
N
LIST_S2
Benign
0.33
T;T
M_CAP
Pathogenic
0.59
D
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.87
T
MutationAssessor
Benign
0.0
.;N
PrimateAI
Uncertain
0.79
T
PROVEAN
Benign
-0.020
N;.
REVEL
Benign
0.25
Sift
Uncertain
0.0060
D;.
Sift4G
Uncertain
0.019
D;D
Polyphen
0.0010
.;B
MutPred
0.25
Loss of relative solvent accessibility (P = 0.0186);Loss of relative solvent accessibility (P = 0.0186);
MVP
0.38
ClinPred
0.40
T
GERP RS
-4.0
Varity_R
0.36
gMVP
0.060

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1434289357; hg19: chr4-123748156; API